logo

For the Inventor, By the Inventor

Dorlisheim, France

Serge Braun

This inventor holds 7 USPTO granted patents and 2 published patent applications. Top assignees: Transgene S.a., Association Francaise Contre Les Myopathies, Other. Active years: 2001-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Serge Braun. Retrieved from https://idiyas.com/inventor/serge-braun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7 

% Patents Active = 85.7

Average Co-Inventor Count = 1.2

ph-index = 2

Forward Citations = 34(Granted Patents)


Company Filing History:

goldMedal6 out of 159 
 
Transgene S.a.
 patents
silverMedal1 out of 11 
 
Association Francaise Contre Les Myopathies
 patents
bronzeMedal1 out of 834,708 
Other
 patents
where one patent can have more than one assignee

Years Active: 2001-2005

Loading Chart...
7 patents (USPTO):Explore Patents
1. 6906041 - Treatment of immune diseases (2005-06-14),
2. 6881724 - Use of magnesium (Mg2+) for the preparation of a therapeutic composition for transfection of a polynucleotide into a cell and compositions useful in gene therapy (2005-04-19),
3. 6723708 - Use of lithium (Li+) for the preparation of a composition for transfection of a polynucleotide into a cell and compositions useful in gene therapy (2004-04-20),
4. 6555377 - Process for production of mammalian cell lines (2003-04-29),
5. 6528312 - Use of G-actin for improving transfection of a polynucleotide into a cell (2003-03-04),
6. 6514756 - Human myoblast cell lines and their uses (2003-02-04),
7. 6258791 - Combination product for enhanced gene delivery comprising a hyaluronidase (2001-07-10),

Title: The Innovative Contributions of Serge Braun

Introduction

Serge Braun is a notable inventor based in Dorlisheim, France. He has made significant contributions to the field of biotechnology, particularly in the treatment of immune diseases. With a total of 7 patents to his name, Braun's work has had a considerable impact on medical science.

Latest Patents

Among his latest patents, one focuses on the treatment of immune diseases. This invention involves the use of a nucleic acid capable of expressing beta-interferon for the preparation of a pharmaceutical composition aimed at treating such diseases. Another significant patent describes the use of magnesium (Mg2+) for the preparation of a therapeutic composition that facilitates the transfection of a polynucleotide into a cell. This innovation is particularly useful in gene therapy, highlighting Braun's commitment to advancing medical treatments.

Career Highlights

Throughout his career, Serge Braun has worked with various organizations, including Transgene S.A. His expertise in biotechnology and pharmaceuticals has positioned him as a key figure in the development of innovative therapies.

Collaborations

Braun has collaborated with several professionals in his field, including Frederic Perraud. These partnerships have further enhanced his research and development efforts.

Conclusion

Serge Braun's contributions to biotechnology and his innovative patents demonstrate his dedication to improving medical treatments. His work continues to influence the field and offers hope for advancements in the treatment of immune diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…